hpv
larg
branch
papillomavirida
famili
group
differ
genera
alpha
numu
beta
gammapapillomavirus
genotyp
classif
papillomavirus
pv
base
gene
sequenc
clinic
divid
two
group
lowrisk
hpv
like
hpv
caus
benign
lesion
wart
benign
papilloma
highrisk
hpv
hrhpv
like
carcinogen
human
global
ratio
malign
diseas
attribut
hpv
infect
estim
almost
cervic
carcinoma
signific
part
anogenit
oropharyng
malign
associ
hpv
infect
current
proven
oncogen
hpv
genet
relat
although
vari
greatli
preval
risk
trigger
malign
lesion
accord
intern
agenc
research
cancer
evalu
iarc
twelv
hpv
type
known
hrhpv
hrhpv
belong
alpha
genu
papillomavirida
famili
oncogen
type
classifi
probabl
carcinogen
hpv
possibl
carcinogen
hpv
still
need
clarifi
rel
simpl
genom
hpv
contain
three
region
upstream
regulatori
region
urr
earli
region
late
region
earli
late
region
encod
six
earli
gene
two
late
gene
respect
among
earli
protein
play
pivot
role
cell
transform
interfer
sever
cell
cycl
pathway
especi
alter
egfr
signal
pathway
degrad
degrad
prb
respect
effect
result
trigger
sever
cascad
event
caus
cell
transform
immun
evas
cancer
progress
oncoprotein
known
ideal
target
immunotherapi
hpvassoci
cancer
sinc
consist
express
almost
cervic
cancer
cell
healthi
cell
essenti
gener
mainten
malign
addit
oncoprotein
structur
differ
human
cell
proteom
therefor
side
effect
healthi
tissu
expect
neglig
current
three
commerci
avail
hpv
prophylact
vaccin
howev
none
show
effect
therapeut
effect
preexist
hpv
infect
associ
cancer
due
high
preval
mortal
urgent
need
develop
effect
therapeut
hpv
vaccin
clearanc
infectionscanc
far
differ
therapeut
vaccin
develop
howev
induc
inadequ
immun
respons
thu
studi
need
develop
effect
therapeut
vaccin
among
variou
therapeut
vaccin
peptidebas
vaccin
appear
attract
candid
treat
cervic
hpvassoci
cancer
peptidebas
vaccin
advantag
easi
product
transport
high
select
multival
capabl
epitop
access
develop
genom
sequenc
techniqu
predict
potenti
b
cell
epitop
open
promis
view
develop
peptidebas
vaccin
infecti
diseas
cancer
current
sever
therapeut
peptidebas
hpv
vaccin
differ
phase
clinic
trial
host
genet
polymorph
influenc
immun
respons
pathogen
target
popul
hla
gene
polymorph
gene
human
genom
vast
hla
polymorph
restrict
phenomenon
result
seriou
problem
vaccin
design
popul
coverag
allel
bind
particular
group
peptid
howev
mani
hlai
allel
classifi
similar
peptidebind
properti
group
cover
hlaa
b
allel
hlai
supertyp
hlaa
hlaa
hlaa
hlaa
hlaa
hlab
hlab
hlab
hlab
hlab
hlab
hlab
repres
group
hla
molecul
bind
similar
set
peptid
previou
studi
shown
presenc
high
immunogen
cytotox
lymphocyt
ctl
epitop
vaccin
formul
essenti
induc
robust
immun
respons
howev
addit
cell
epitop
significantli
augment
strength
durat
ctl
commonli
recogn
intracellularorigin
peptid
present
mhci
molecul
accommod
peptid
residu
ideal
length
residu
helper
lymphocyt
htl
commonli
recogn
extracellularorigin
peptid
present
mhcii
molecul
accommod
peptid
residu
even
ideal
length
strength
interact
cell
receptor
peptidemhc
complex
pmhc
depend
present
peptid
mhc
structur
bind
peptid
mhci
molecul
select
stage
way
peptid
present
bioinformat
tool
predict
potenti
immunogen
epitop
thousand
epitop
short
time
gener
algorithm
tool
rang
one
program
determin
peptid
mhc
molecul
bind
data
base
structur
similar
molecular
model
molecular
dock
peptid
bind
specif
mhc
molecul
sequenc
similar
therefor
peptid
sequenc
pattern
use
predict
bind
mhc
molecul
recent
year
accuraci
method
increas
strikingli
natur
epitop
recogn
high
specif
improv
perform
achiev
expand
experiment
bind
data
avail
immun
epitop
databas
iedb
analysi
resourc
http
wwwiedborg
improv
machinelearn
algorithm
regard
fundament
import
epitop
predict
vaccin
develop
investig
best
potenti
cell
epitop
oncoprotein
four
preval
hrhpv
genotyp
world
iran
shown
fig
twostep
plan
design
identifi
probabl
cell
epitop
fig
first
step
mhci
ii
bind
mhci
process
mhci
popul
coverag
mhci
immunogen
predict
analys
second
step
mhci
ii
proteinpeptid
dock
epitop
conserv
crossreact
host
antigen
analys
consid
second
step
analys
perform
select
peptid
first
step
jan
order
prioriti
refseq
review
unreview
sequenc
hrhpv
oncoprotein
retriev
nation
center
biotechnolog
inform
databas
ncbi
http
wwwncbinlmnihgov
uniprotkbswissprot
databas
http
wwwuniprotorg
isoform
sequenc
oncoprotein
retriev
hpv
cell
antigen
databas
http
cvcdfciharvardeduhpvhtmlsearchphp
sequenc
access
support
inform
file
bind
epitop
mhci
molecul
essenti
step
antigen
present
ctl
herein
predict
four
onlin
server
illustr
tabl
hla
supertyp
frequent
occur
hlai
allel
provid
server
includ
analysi
howev
allel
eg
hlab
provid
allel
group
ie
hlab
avail
use
allel
group
instead
allel
use
human
mous
allel
allel
group
provid
support
inform
tabl
server
predict
bind
peptid
known
mhc
molecul
use
ann
method
train
combin
natur
elut
ligand
human
mous
mhci
allel
bind
affin
data
mhc
molecul
human
mous
cattl
primat
swine
besid
user
perform
predict
custom
mhci
molecul
upload
fulllength
sequenc
studi
predict
perform
peptid
frequent
occur
human
mhci
allel
mhci
mous
allel
pr
threshold
strong
weak
binder
set
respect
peptid
pr
appli
analysi
rankpep
predict
binder
peptid
given
protein
sequenc
sequenc
align
mhci
ii
molecul
algorithm
rankpep
base
comparison
sequenc
similar
use
positionspecif
score
matric
pssm
method
employ
profil
group
align
peptid
recogn
bind
specif
mhc
molecul
creat
consensu
sequenc
determin
common
residu
posit
alloc
optim
score
consensu
sequenc
compar
score
subject
peptid
optim
score
give
peptid
percentil
optim
valu
comparison
final
highlight
strong
binder
red
herein
predict
made
frequent
occur
hlai
allel
server
provid
common
length
epitop
mhc
allel
thu
use
allel
provid
epitop
length
shown
togeth
given
support
inform
tabl
syfpeithi
http
databas
publish
verifi
peptid
sequenc
human
mous
organ
known
natur
binder
mhci
ii
molecul
syfpeithi
analyz
peptid
bind
predict
specif
mhci
allel
score
system
evalu
everi
residu
queri
give
arbitrari
valu
accord
whether
anchor
auxiliari
anchor
prefer
residu
alloc
valu
residu
slightli
prefer
particular
posit
ideal
anchor
residu
residu
exhibit
advers
effect
bind
abil
sum
valu
score
peptid
maxim
score
could
vari
differ
mhc
allel
herein
predict
made
frequent
occur
hlai
allel
allel
epitop
length
set
everi
predict
pmhc
got
score
less
refer
sequenc
score
exclud
analysi
allelespecif
refer
sequenc
select
rankpep
consensu
sequenc
syfpeithi
predict
epitop
whichev
got
highest
score
syfpeihi
server
refer
sequenc
sourc
score
given
support
inform
tabl
studi
mhcii
bind
predict
made
iedb
mhcii
bind
predictor
http
toolsiedborgmhcii
iedb
possess
seven
predict
method
mhcii
bind
predict
iedbrecommend
consensu
netmhciipan
nn
align
smmalign
combinatori
librari
sturniolo
method
herein
iedbrecommend
method
use
peptid
pr
select
analysi
predict
made
human
allel
iedb
refer
set
three
mous
allel
given
support
inform
tabl
server
fundament
set
epitop
length
iedbrecommend
method
particip
predict
process
offer
core
peptid
predict
epitop
associ
mhcii
core
peptid
mhci
predict
epitop
determin
mhci
epitop
core
peptid
mhcii
epitop
mhci
cell
epitop
process
predict
oncoprotein
made
iedb
combin
predictor
http
toolsiedborgprocess
tool
combin
predictor
three
main
step
mhci
antigen
present
pathway
proteasom
process
transport
associ
antigen
process
tap
transport
mhci
bind
calcul
total
process
score
predict
epitop
allow
user
choos
method
ann
smm
smmpmbec
netmhcpan
netmhccon
pickpocket
method
bind
predict
current
updat
iedb
team
chang
choic
recommend
predict
method
process
tool
netmhcpan
rather
consensu
sinc
process
tool
requir
valu
consensu
method
provid
furthermor
netmhcpan
provid
mhc
allel
perform
predict
well
recent
comparison
two
type
proteasom
housekeep
type
express
instinct
immuno
type
provok
secret
immunoproteasom
believ
improv
effici
antigen
present
studi
immunoproteasom
option
select
program
output
everi
predict
epitop
consist
proteasom
score
tap
score
mhc
score
process
score
proteasom
tap
score
total
score
proteasom
tap
mhc
score
mhci
tap
score
system
calcul
valu
bind
peptid
ntermin
precursor
tap
molecul
higher
tap
score
higher
transport
rate
herein
analysi
made
human
mous
mhci
allel
use
later
iedb
bind
predict
iedbrecommend
method
default
set
program
epitop
nm
hlai
allel
nm
allel
includ
analysi
sever
factor
could
clarifi
differ
epitop
nonepitop
peptid
essenti
factor
epitop
immunogen
ie
could
recogn
cell
amino
acid
particularli
larg
aromat
side
chain
especi
tryptophan
phenylalanin
isoleucin
associ
immunogen
moreov
posit
peptid
critic
immunogen
studi
mhci
immunogen
predict
epitop
determin
iedb
web
server
http
toolsiedborgimmunogen
tool
use
properti
amino
acid
locat
predict
immunogen
pmhc
default
option
select
specifi
posit
queri
peptid
mask
analysi
mask
posit
also
suggest
frequent
human
mhci
allel
hlaa
iedb
popul
coverag
predict
tool
http
toolsiedborgpopul
use
predict
hlai
popul
coverag
predict
epitop
first
step
tool
accept
target
popul
two
queri
level
areacountryethn
ethnic
alon
integr
allel
frequenc
inform
retriev
allel
frequenc
net
databas
afnd
http
wwwallelefrequenciesnetdefaultasp
iedb
also
accept
custom
popul
allel
frequenc
defin
user
sinc
hlai
hlaii
cell
epitop
elicit
immun
respons
two
differ
cell
popul
ctl
htl
respect
server
provid
three
differ
popul
coverag
mode
hlai
lone
hlaii
lone
hlai
hlaii
togeth
herein
mhci
promiscu
predict
epitop
bind
hlai
allel
pr
enter
input
analysi
world
popul
primari
aim
molecular
dock
predict
bind
site
ligand
protein
receptor
surfac
dock
model
ligand
recogn
site
studi
bind
abil
first
step
select
peptid
human
mous
mhc
molecul
analyz
cabsdock
http
biocompchemuweduplcabsdock
server
server
use
multistag
procedur
involv
multipl
program
chain
cab
model
heart
detail
inform
stage
given
support
inform
file
also
fig
show
pipelin
cabsdock
protocol
cabsdock
get
structur
receptor
sequenc
peptid
obligatori
input
furthermor
nonobligatori
input
recommend
could
improv
output
studi
duplic
dock
peptid
dock
total
done
signific
humanmous
mhci
ii
molecul
least
one
wellstructur
protein
data
bank
pdb
file
rcsb
protein
data
bank
http
wwwrcsborg
shown
tabl
pdb
file
complex
peptid
ligand
xray
crystallographi
solut
molecul
heteroatom
thu
excess
molecul
well
redund
mhc
molecul
remov
execut
dock
process
sinc
bind
site
epitop
mhc
molecul
wellknown
previous
unlik
region
bind
mask
analysi
cabsdock
return
ten
repres
model
medoid
bestsimul
model
rank
cluster
densiti
cd
cluster
densiti
equal
number
element
cluster
divid
averag
ligand
root
mean
squar
deviat
rmsd
higher
cd
valu
impli
greater
accuraci
ligand
rmsd
valu
show
differenti
measur
cluster
element
guidelin
rmsd
mean
high
accuraci
rmsd
mean
medium
accuraci
rmsd
mean
low
accuraci
herein
rmsd
cd
bestsimul
model
select
analysi
best
model
highest
cd
valu
necessarili
toprank
model
case
peptid
attach
bind
site
properli
thu
malform
model
exclud
analysi
import
note
due
differ
frequenc
mhc
allel
human
popul
equal
cd
valu
differ
mhc
allel
equal
valu
regard
popul
coverag
thu
involv
effect
popul
coverag
cd
valu
everi
model
multipli
allel
popul
coverag
divid
hundr
facil
obtain
weight
index
sum
hlai
ii
weight
index
peptid
calcul
get
total
dock
score
td
use
score
compar
candid
peptid
first
time
td
formul
use
purpos
formula
also
applic
similar
dock
score
obtain
server
use
highli
conserv
epitop
vaccin
formul
reduc
risk
tumor
immun
escap
provid
broader
protect
differ
viru
strain
genotyp
thu
conserv
area
prefer
use
therapeut
vaccin
appropri
epitop
herein
epitop
conserv
analys
first
step
select
peptid
done
three
level
select
peptid
first
step
analyz
find
interstrain
intertyp
conserv
percentag
iedb
tool
conserv
across
antigen
http
toolsiedborgconserv
interhrhpv
conserv
analysi
done
iedb
expasi
clustalw
server
http
embnetvitalitchsoftwareclustalwhtml
crossreact
host
antigen
caus
advers
immun
respons
therefor
select
peptid
first
step
check
similar
mous
human
proteom
ncbi
blastp
tool
http
blastncbinlmnihgovblastcgi
regard
studi
differ
peptid
usual
get
differ
scoresrank
differ
analys
inconsist
indic
result
need
analyz
integr
approach
inde
integr
approach
practic
effici
condit
comparison
analysi
analysi
filter
approach
epitop
chosen
next
analysi
gotten
accept
score
previou
analysi
herein
integr
approach
appli
step
epitop
select
sinc
ultim
goal
discoveri
therapeut
epitop
use
human
vaccin
scoresrank
human
allel
use
rank
epitop
studi
howev
investig
usual
test
therapeut
vaccin
mous
speci
preclin
trial
thu
current
studi
bind
statu
predict
epitop
mous
mhci
allel
also
studi
sever
bind
predictor
molecular
dock
well
state
ctlmediat
respons
play
crucial
role
kill
malign
cell
besid
bind
epitop
mhci
molecul
select
step
antigen
present
ctl
therefor
first
step
select
made
primarili
comparison
obtain
mhci
bind
process
immunogen
scoresrank
popul
coverag
percentag
howev
mhcii
bind
rank
actual
secondari
import
select
process
ad
advantag
addit
popul
coverag
dual
applic
first
determin
coverag
given
peptid
target
popul
second
best
index
summar
evalu
hlai
bind
predict
sinc
calcul
result
hlai
bind
predict
analys
first
step
ten
peptid
tabl
hpv
genotyp
oncoprotein
peptid
total
got
better
result
first
step
analys
select
second
step
analys
includ
proteinpeptid
molecular
dock
epitop
conserv
crossreact
host
antigen
individu
detail
result
mhci
ii
bind
file
mhci
immunogen
file
mhci
popul
coverag
file
predict
well
mhci
ii
molecular
dock
file
epitop
conserv
file
analys
given
support
inform
excel
file
inde
cabsdock
return
ten
repres
medoid
bestsimul
model
rank
cluster
densiti
cd
cluster
densiti
deriv
two
factor
number
element
cluster
averag
ligand
rmsd
advantag
server
second
step
five
peptid
ten
select
peptid
first
step
tabl
got
better
result
analys
step
select
finalpredict
epitop
none
final
predict
epitop
show
sequenc
similar
mous
human
proteom
high
preval
mortal
oncogen
infecti
pathogen
hpv
helicobact
pylori
caus
seriou
problem
human
current
peopl
infect
hrhpv
show
normal
cytolog
precancer
lesion
treatment
option
caus
diseas
progress
toward
invas
carcinoma
case
unfortun
fdaapprov
immunotherapi
exist
preexist
hpv
infect
relat
cancer
date
immunotherapi
hpvassoci
cancer
dna
peptidebas
vaccin
depend
recognit
highli
immunogen
epitop
induc
robust
specif
immun
respons
particularli
cellmedi
respons
malign
cell
primari
aim
studi
predict
cell
epitop
oncoprotein
use
comprehens
twostep
select
plan
protein
chose
play
pivot
role
cell
transform
immun
evas
mainten
malign
well
perman
express
malign
cell
express
oncoprotein
occur
earli
phase
hpv
infect
evid
indic
play
promin
role
genesi
hpvassoci
cancer
essenti
cancer
progress
sinc
hpv
genom
integr
host
genom
usual
result
disrupt
gene
therefor
target
protein
provid
opportun
treatment
hpv
infect
prevent
precancer
lesion
progress
establish
carcinoma
genotyp
hrhpv
involv
genesi
epitheli
tissu
malign
thu
studi
target
due
high
preval
hpvassoci
cancer
especi
cervic
carcinoma
sever
limit
epitop
predict
major
drawback
peptidebas
vaccin
low
immunogen
mani
studi
focus
enhanc
immunogen
use
immun
stimul
agent
adjuv
avoid
problem
anoth
solut
use
agonist
epitop
epitop
immunogen
crucial
factor
vaccin
develop
howev
mani
known
natur
epitop
analyz
silico
iedb
mhci
immunogen
predictor
obtain
high
score
therefor
studi
epitop
select
base
integr
approach
one
analysi
play
import
role
alon
certain
drawback
associ
function
method
invent
mhcpeptid
bind
predict
reason
sever
predictor
molecular
dock
program
use
augment
predict
accuraci
web
tool
develop
mhcii
epitop
predict
sinc
mhcii
groov
bind
peptid
variabl
length
differ
peptid
differ
number
residu
nterminu
first
anchor
exact
assign
mhcii
core
peptid
would
difficult
problem
reduc
success
rate
predict
tool
therefor
mhcii
predict
tool
usual
make
epitop
predict
accur
note
mhci
molecul
cancer
immunotherapi
ctlmediat
respons
play
central
role
erad
malign
cell
bind
epitop
mhci
molecul
essenti
step
antigen
present
ctl
thu
studi
predict
epitop
primarili
select
mhci
bind
process
score
howev
mhcii
bind
score
actual
secondari
import
epitop
select
process
extra
advantag
addit
sever
essenti
determin
significantli
affect
outcom
antigen
process
immunogen
popul
coverag
conserv
crossreact
host
antigen
vaccin
develop
requir
comprehens
approach
cover
effectu
element
cover
studi
primari
aim
molecular
dock
recognit
bind
site
ligand
protein
receptor
surfac
dock
model
ligand
recogn
site
studi
cabsdock
server
use
molecular
dock
analys
cabsdock
sever
main
advantag
method
requir
data
peptid
structur
bind
site
dock
process
peptid
conform
entir
flexibl
possibl
appli
dynam
conform
chang
receptor
structur
exclud
receptor
region
dock
search
lead
effici
search
vicin
bind
site
sensibl
time
comparison
proteinligand
small
molecul
dock
proteinpeptid
dock
analysi
problemat
sinc
signific
conform
chang
occur
process
gener
rule
much
length
queri
peptid
longer
torsion
conform
flexibl
addit
comparison
proteinprotein
interact
proteinpeptid
dock
transient
bind
affin
notabl
weaker
factor
make
structur
predict
long
peptid
challeng
therefor
studi
peptid
prefer
select
compar
possibl
length
also
prefer
mhci
molecul
epitop
mhcii
molecul
core
peptid
epitop
moreov
expans
ctl
epitop
longer
peptid
may
creat
practic
altern
contain
htl
ctl
epitop
especi
htl
epitop
cover
ctl
epitop
recogn
larg
number
previou
studi
use
silico
analys
epitop
predict
differ
pathogen
howev
predict
cell
epitop
induc
strong
respons
remain
big
challeng
therapeut
hpv
vaccin
mani
candid
design
trigger
activ
ctl
htl
mostli
target
two
major
hpv
oncoprotein
studi
oncoprotein
well
sever
clinic
trial
launch
immunotherapi
hpvassoci
cancer
although
immunogen
induc
suffici
cellular
immun
erad
malign
cell
complet
studi
suggest
use
slp
contain
htl
ctl
epitop
led
potenc
durabl
cell
reactiv
vivo
comparison
minim
ctl
epitop
pioneer
hpv
epitop
studi
feltkamp
et
al
recogn
sequenc
rahynivtf
mhci
epitop
provok
ctlmediat
respons
erad
establish
hpv
tumor
cell
mice
sequenc
first
predict
epitop
studi
well
kumar
et
al
studi
oncoprotein
predict
candid
tcell
bcell
epitop
screen
potent
epitop
mhci
molecul
accord
pr
immunogen
score
use
iedb
mhci
bind
immunogen
predictor
found
potent
epitop
safrcfivyiifvi
lowest
pr
highest
immunogen
score
ie
respect
notabl
second
predict
epitop
safrcfivi
ntermin
part
safrcfivyiifvi
first
predict
epitop
flihtharf
ctermin
part
third
epitop
studi
vyiplflihtharf
tsang
et
al
scan
oncoprotein
match
peptid
consensu
motif
bind
peptid
bima
algorithm
employ
rank
probabl
bind
peptid
accord
predict
onehalftim
dissoci
pmhc
three
potenti
ctl
predict
epitop
protein
klpqlctel
kiseyrhyc
qqynkplcdl
three
protein
ymldlqpet
tlheymldl
rtledllmgt
select
show
immunogen
peptid
enhanc
agonist
epitop
use
klpqlctel
tlheymldl
sequenc
seventh
fifth
predict
epitop
studi
respect
experiment
evid
hrhpvderiv
epitop
literatur
mostli
limit
oncoprotein
among
firststep
predict
epitop
fllcfcvll
yiifvyipl
epitop
fafrdlcivi
cyslygttl
vydfafrdl
kfyskisey
klpqlctel
iseyrhyci
eyrhycysl
klpdlctel
fafkdlfvv
klpdlctel
epitop
rahynivtf
ledllmgtl
tlheymldl
llmgtlgiv
qaepdrahi
gtlgivcpi
fqqlflntl
tlqdivlhl
epitop
report
tcell
epitop
experiment
besid
ivyrdgnpi
cyslygttl
klpqlctel
iseyrhyci
epitop
rahynivtf
gtlgivcpi
epitop
also
report
hla
ligand
other
novel
epitop
also
requir
experiment
studi
valid
far
know
first
time
labori
silico
studi
epitop
predict
oncoprotein
investig
altogeth
moreov
previou
studi
usual
one
predictor
tool
use
make
epitop
predict
sever
tool
use
integr
approach
employ
make
conclus
believ
predict
epitop
valuabl
candid
vitro
vivo
therapeut
vaccin
studi
addit
introduct
ten
epitop
hpv
genotyp
oncoprotein
first
step
studi
show
region
oncoprotein
rich
epitop
thu
suitabl
use
design
slp
notabl
previou
vivo
studi
conduct
use
slp
oncoprotein
particular
oncoprotein
furthermor
twostep
plan
silico
studi
step
includ
sever
analys
find
proper
epitop
integr
approach
would
provid
basi
ration
epitop
predict
howev
could
effici
ad
use
analys
studi
recommend
peptid
bind
assay
design
polyepitop
construct
includ
epitop
expans
minim
ctl
epitop
longer
peptid
slp
use
variou
adjuv
involv
deliveri
rout
mous
immun
design
construct
evalu
immun
respons
cytokin
antibodi
ctl
tumor
growth
find
best
construct
clinic
trial
import
improp
vaccin
design
immunosuppress
microenviron
known
main
reason
failur
cancer
immunotherapi
therapeut
cancer
vaccin
